# Elena Vasquez, PhD

## Experience

**Sanofi** | Senior Biostatistician | 2021–Present

- Lead statistical design for 3 concurrent Phase III oncology trials
- Developed adaptive enrichment design that reduced required sample size by 22% for the BEACON-3 trial
- Reduced analysis time by 60% through implementation of automated Bayesian pipeline
- Built internal R package for Bayesian subgroup analysis used by 15 statisticians across 3 departments

**Dana-Farber Cancer Institute** | Biostatistician II | 2018–2021

- Designed and analyzed Phase I-II dose-finding studies in immuno-oncology
- Published novel Bayesian dose-optimization method in Statistics in Medicine (2020)
- Led team of 8 analysts in developing real-world evidence platform using Snowflake and dbt
- Contributed to 5 successful NIH R01 grant applications totaling $8.7M in funding

**Vertex Pharmaceuticals** | Statistical Consultant | 2019–2020

- Designed group sequential boundary for pivotal CF trial that maintained 90% power with 18% fewer patients
- Developed proprietary machine learning model for patient stratification with 95% accuracy

## Education

PhD Biostatistics, Harvard T.H. Chan School of Public Health, 2018
MS Statistics, University of Michigan, 2014
BS Mathematics, UCLA, 2012 — Magna Cum Laude

## Publications

- Adaptive Enrichment Designs with Biomarker Subgroups: Balancing Type I Error and Power. Biometrics, 2019.
- Bayesian Dose-Optimization in Immuno-Oncology: A Practical Framework. Statistics in Medicine, 2020.

## Skills

- Expert in R, SAS, and Snowflake for data analysis
- Proficient in Python, Stan, dbt for data pipeline development
- Bayesian methods, survival analysis, causal inference, adaptive trial design
